WallStreetZenWallStreetZen

NASDAQ: IMDX
Insight Molecular Diagnostics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Insight Molecular Diagnostics earnings were -$58.3M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest IMDX earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$6.7M, down 80.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IMDX reported annual earnings of -$60.9M, with 112.1% growth.

IMDX earnings history

Current Revenue
$3.8M
Current Earnings
-$58.3M
Current Profit Margin
-1,516.1%

IMDX Return on Equity

Current Company
-767.7%
Current Industry
-10.3%
Current Market
31.4%
IMDX's Return on Equity (-767.7%)... subscribe to Premium to read more.
High Return on Equity Performance

IMDX undefined

Current Company
-97%
Current Industry
6%
IMDX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IMDX announces earnings.

IMDX undefined

Current Company
-114.77%
Current Industry
10.8%
IMDX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IMDX vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IMDX-$56.44M-$58.26MN/A-$3.90
PREN/A-$48.13MN/A-$3.83
XGN-$10.66M-$15.51MN/A-$0.84
VNRX-$22.34M-$24.02MN/A-$0.27
FONR$17.38M$7.90M-6.63%$1.27
View Top Diagnostic & Research Stocks

Insight Molecular Diagnostics Earnings Reports & History FAQ

What were Insight Molecular Diagnostics's earnings last quarter?

On IMDX's earnings call on Invalid Date, Insight Molecular Diagnostics (NASDAQ: IMDX) reported Q1 2025 earnings per share (EPS) of -$0.26, up 76.99% year over year. Total IMDX earnings for the quarter were -$6.67 million. In the same quarter last year, Insight Molecular Diagnostics's earnings per share (EPS) was -$1.13.

If you're new to stock investing, here's how to buy Insight Molecular Diagnostics stock.

Is Insight Molecular Diagnostics profitable or losing money?

As of the last Insight Molecular Diagnostics earnings report, Insight Molecular Diagnostics is currently losing money. Insight Molecular Diagnostics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$58.26 million, a 42.59% increase year over year.

What was IMDX's earnings growth in the past year?

As of Insight Molecular Diagnostics's earnings date in Invalid Date, Insight Molecular Diagnostics's earnings has grown year over year. IMDX earnings in the past year totalled -$58.26 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.